1. Home
  2. HAO vs WINT Comparison

HAO vs WINT Comparison

Compare HAO & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAO
  • WINT
  • Stock Information
  • Founded
  • HAO 2018
  • WINT 1992
  • Country
  • HAO China
  • WINT United States
  • Employees
  • HAO N/A
  • WINT N/A
  • Industry
  • HAO
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HAO
  • WINT Health Care
  • Exchange
  • HAO NYSE
  • WINT Nasdaq
  • Market Cap
  • HAO 3.3M
  • WINT 3.6M
  • IPO Year
  • HAO 2024
  • WINT 1995
  • Fundamental
  • Price
  • HAO $1.52
  • WINT $0.76
  • Analyst Decision
  • HAO
  • WINT Hold
  • Analyst Count
  • HAO 0
  • WINT 1
  • Target Price
  • HAO N/A
  • WINT $350.00
  • AVG Volume (30 Days)
  • HAO 133.5K
  • WINT 211.6K
  • Earning Date
  • HAO 06-09-2025
  • WINT 05-16-2025
  • Dividend Yield
  • HAO N/A
  • WINT N/A
  • EPS Growth
  • HAO N/A
  • WINT N/A
  • EPS
  • HAO 0.19
  • WINT N/A
  • Revenue
  • HAO $48,970,924.00
  • WINT N/A
  • Revenue This Year
  • HAO N/A
  • WINT N/A
  • Revenue Next Year
  • HAO N/A
  • WINT N/A
  • P/E Ratio
  • HAO $7.84
  • WINT N/A
  • Revenue Growth
  • HAO 15.04
  • WINT N/A
  • 52 Week Low
  • HAO $0.84
  • WINT $0.73
  • 52 Week High
  • HAO $203.00
  • WINT $737.44
  • Technical
  • Relative Strength Index (RSI)
  • HAO 53.90
  • WINT 32.48
  • Support Level
  • HAO $0.96
  • WINT $0.73
  • Resistance Level
  • HAO $2.31
  • WINT $0.85
  • Average True Range (ATR)
  • HAO 0.30
  • WINT 0.06
  • MACD
  • HAO -0.00
  • WINT 0.03
  • Stochastic Oscillator
  • HAO 41.70
  • WINT 14.09

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

Share on Social Networks: